Skip to main content

Books in Drug discovery

31-40 of 69 results in All results

Social Aspects of Drug Discovery, Development and Commercialization

  • 1st Edition
  • February 11, 2016
  • Odilia Osakwe + 1 more
  • English
  • Paperback
    9 7 8 - 0 - 1 2 - 8 0 2 2 2 0 - 7
  • eBook
    9 7 8 - 0 - 1 2 - 8 0 2 4 9 7 - 3
Social Aspects of Drug Discovery, Development and Commercialization provides an insightful analysis of the drug discovery and development landscape as it relates to society. This book examines the scientific, legal, philosophical, economic, political, ethical and cultural factors that contribute to drug development. The pharmaceutical industry is under scrutiny to develop safer and more effective drugs in a quicker and more affordable manner. Recent criticism and debates have emphasized varying opinions on the issues concerning the drug discovery and development process. This book provides thoughtful and valuable discussions and analysis of the social challenges and potential opportunities through all stages of the pharmaceutical process, from inception through marketing. With a unique focus on the social factors that increasingly play a role in how drug development is planned, structured, and executed throughout the drug product lifecycle, this is an essential resource for students, professors, and researchers who seek a better understanding of the interface between the pharmaceutical industry, health care systems, and society.

Progress in Medicinal Chemistry

  • 1st Edition
  • Volume 55
  • February 1, 2016
  • G. Lawton + 1 more
  • English
  • Hardback
    9 7 8 - 0 - 4 4 4 - 6 3 7 1 5 - 4
  • eBook
    9 7 8 - 0 - 4 4 4 - 6 3 7 4 2 - 0
Progress in Medicinal Chemistry provides a review of eclectic developments in medicinal chemistry. This volume includes chapters covering recent advances in cancer therapeutics, fluorine in medicinal chemistry, a perspective on the next generation of antibacterial agents derived by manipulation of natural products, a new era for Chagas Disease drug discovery? and imaging in drug development.

Synthesis of Best-Seller Drugs

  • 1st Edition
  • January 7, 2016
  • Ruben Vardanyan + 1 more
  • English
  • Paperback
    9 7 8 - 0 - 1 2 - 4 1 1 4 9 2 - 0
  • eBook
    9 7 8 - 0 - 1 2 - 4 1 1 5 2 4 - 8
Synthesis of Best-Seller Drugs is a key reference guide for all those involved with the design, development, and use of the best-selling drugs. Designed for ease of use, this book provides detailed information on the most popular drugs, using a practical layout arranged according to drug type. Each chapter reviews the main drugs in each of nearly 40 key therapeutic areas, also examining their classification, novel structural features, models of action, and synthesis. Of high interest to all those who work in the captivating areas of biologically active compounds and medicinal drug synthesis, in particular medicinal chemists, biochemists, and pharmacologists, the book aims to support current research efforts, while also encouraging future developments in this important field.

Frontiers in Computational Chemistry: Volume 2

  • 1st Edition
  • November 24, 2015
  • Zaheer Ul-Haq + 1 more
  • English
  • Paperback
    9 7 8 - 1 - 6 0 8 0 5 - 9 7 9 - 9
  • eBook
    9 7 8 - 1 - 6 0 8 0 5 - 9 7 8 - 2
Frontiers in Computational Chemistry, originally published by Bentham and now distributed by Elsevier, presents the latest research findings and methods in the diverse field of computational chemistry, focusing on molecular modeling techniques used in drug discovery and the drug development process. This includes computer-aided molecular design, drug discovery and development, lead generation, lead optimization, database management, computer and molecular graphics, and the development of new computational methods or efficient algorithms for the simulation of chemical phenomena including analyses of biological activity. In Volume 2, the authors continue the compendium with nine additional perspectives in the application of computational methods towards drug design. This volume covers an array of subjects from modern hardware advances that accelerate new antibacterial peptide identification, electronic structure methods that explain how singlet oxygen damages DNA, to QSAR model validation, the application of DFT and DFRT methods on understanding the action of nitrogen mustards, the design of novel prodrugs using molecular mechanics and molecular orbital methods, computational simulations of lipid bilayers, high throughput screening methods, and more.

Drug Discovery in Cancer Epigenetics

  • 1st Edition
  • November 19, 2015
  • Gerda Egger + 1 more
  • English
  • Hardback
    9 7 8 - 0 - 1 2 - 8 0 2 2 0 8 - 5
  • eBook
    9 7 8 - 0 - 1 2 - 8 0 2 4 9 2 - 8
Drug Discovery in Cancer Epigenetics is a practical resource for scientists involved in the discovery, testing, and development of epigenetic cancer drugs. Epigenetic modifications can have significant implications for translational science as biomarkers for diagnosis, prognosis or therapy prediction. Most importantly, epigenetic modifications are reversible and epigenetic players are found mutated in different cancers; therefore, they provide attractive therapeutic targets. There has been great interest in developing and testing epigenetic drugs, which inhibit DNA methyltransferases, histone modifying enzymes or chromatin reader proteins. The first few drugs are already FDA approved and have made their way into clinical settings. This book provides a comprehensive summary of the epigenetic drugs currently available and aims to increase awareness in this area to foster more rapid translation of epigenetic drugs into the clinic.

Basic Principles of Drug Discovery and Development

  • 1st Edition
  • April 24, 2015
  • Benjamin E. Blass
  • English
  • Paperback
    9 7 8 - 0 - 1 2 - 4 1 1 5 0 8 - 8
  • eBook
    9 7 8 - 0 - 1 2 - 4 1 1 5 2 5 - 5
Basic Principles of Drug Discovery and Development presents the multifaceted process of identifying a new drug in the modern era, providing comprehensive explanations of enabling technologies such as high throughput screening, structure based drug design, molecular modeling, pharmaceutical profiling, and translational medicine, all areas that have become critical steps in the successful development of marketable therapeutics. The text introduces the fundamental principles of drug discovery and development, also discussing important drug targets by class, in vitro screening methods, medicinal chemistry strategies in drug design, principles in pharmacokinetics and pharmacodynamics, animal models of disease states, clinical trial basics, and selected business aspects of the drug discovery process. It is designed to enable new scientists to rapidly understand the key fundamentals of drug discovery, including pharmacokinetics, toxicology, and intellectual property."

Understanding the Basics of QSAR for Applications in Pharmaceutical Sciences and Risk Assessment

  • 1st Edition
  • March 3, 2015
  • Kunal Roy + 2 more
  • English
  • Paperback
    9 7 8 - 0 - 1 2 - 8 0 1 5 0 5 - 6
  • eBook
    9 7 8 - 0 - 1 2 - 8 0 1 6 3 3 - 6
Understanding the Basics of QSAR for Applications in Pharmaceutical Sciences and Risk Assessment describes the historical evolution of quantitative structure-activity relationship (QSAR) approaches and their fundamental principles. This book includes clear, introductory coverage of the statistical methods applied in QSAR and new QSAR techniques, such as HQSAR and G-QSAR. Containing real-world examples that illustrate important methodologies, this book identifies QSAR as a valuable tool for many different applications, including drug discovery, predictive toxicology and risk assessment. Written in a straightforward and engaging manner, this is the ideal resource for all those looking for general and practical knowledge of QSAR methods.

Rare Diseases and Orphan Drugs

  • 1st Edition
  • May 26, 2014
  • Jules J. Berman
  • English
  • Hardback
    9 7 8 - 0 - 1 2 - 4 1 9 9 8 8 - 0
  • eBook
    9 7 8 - 0 - 1 2 - 4 2 0 0 0 9 - 8
Rare Diseases and Orphan Drugs shows that much of what we now know about common diseases has been achieved by studying rare diseases. It proposes that future advances in the prevention, diagnosis, and treatment of common diseases will come as a consequence of our accelerating progress in the field of rare diseases. Understanding the complex steps in the development of common diseases, such as cancer, cardiovascular disease, and metabolic diseases, has proven a difficult problem. Rare diseases, however, are often caused by aberrations of a single gene. In rare diseases, we may study how specific genetic defects can trigger a series of events that lead to the expression of a particular disease. Often, the disease process manifested in a certain rare disease is strikingly similar to the disease process observed in a common disease. This work ties the lessons learned about rare diseases to our understanding of common ones. Chapters covering the number of common diseases are minimized, while rare diseases are introduced as single diseases or as members of diseases classes. After reading this book, readers will appreciate how further research into the rare diseases may lead to new methods for preventing, diagnosing, and treating all diseases, rare or common.

A Pharmacology Primer

  • 4th Edition
  • March 26, 2014
  • Terry P. Kenakin
  • English
  • Hardback
    9 7 8 - 0 - 1 2 - 4 0 7 6 6 3 - 1
  • eBook
    9 7 8 - 0 - 1 2 - 4 0 7 6 8 9 - 1
A Pharmacology Primer: Techniques for More Effective and Strategic Drug Discovery, 4th Edition features the latest ideas and research about the application of pharmacology to the process of drug discovery to equip readers with a deeper understanding of the complex and rapid changes in this field. Written by well-respected pharmacologist, Terry P. Kenakin, this primer is an indispensable resource for all those involved in drug discovery. This edition has been thoroughly revised to include material on data-driven drug discovery, biased signaling, structure-based drug design, drug activity screening, drug development (including pharmacokinetics and safety Pharmacology), and much more. With more color illustrations, examples, and exercises throughout, this book remains a top reference for all industry and academic scientists and students directly involved in drug discovery, or pharmacologic research.

Transporters in Drug Discovery and Development

  • 1st Edition
  • October 31, 2013
  • Yurong Lai
  • English
  • Hardback
    9 7 8 - 1 - 9 0 7 5 6 8 - 2 1 - 3
  • eBook
    9 7 8 - 1 - 9 0 8 8 1 8 - 2 8 - 7
Written by a leading researcher in the field, Transporters in Drug Discovery and Development provides a comprehensive and practical guide to drug transporter families that are the most important for drug discovery and development. It covers: an overview of transporter families and organ distribution; clinical relevant drug-drug interaction; clinical relevant polymorphism; drug transporter related pharmacokinetic, pharmacodynamics and toxicity; in vitro/in vivo probes of drug transport studies; the practical methodologies of industrial transporter screening and translational aspect in drug discovery and developments.